focus -WSS

focus

author：explore 2025-10-02 23:59:58 - browse：4

President Joe Biden talks in the Roosevelt Room of the White House, in front of a painting of Theodore Roosevelt on a horse back — politics coverage from STAT — President Biden MANDEL NGAN/AFP via Getty Images

WASHINGTON — The White House is throwing its support behind a controversial authority that allows the government to undermine patent rights for certain high-priced medicines. It’s an early step that could have major ramifications for the American pharmaceutical industry, depending on whether and how federal officials actually use the authority.

The administration issued a framework for the National Institutes of Health to more broadly use so-called “march-in rights” — a policy that allows it to invalidate patent rights from drugmakers whose products rely on federally funded research. The framework lays out when the agency might assert this authority, and endorse using a drug’s price in that determination.

“We’ll make clear that when drug companies won’t sell taxpayer funded drugs at reasonable prices, we will be prepared to allow other companies to provide those drugs for less,” White House National Economic Advisor Lael Brainard told reporters. “These authorities are in existing laws, the last administration just didn’t want to allow them to be used in this way.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： What Henrietta Lacks's story taught me about my role as a doctor

focus

WSS

What do new weight loss drugs mean for bariatric surgery?

My chronic pain journey would have been easier knowing 5 things % STAT

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

Sophia Smith scores twice for US in in 3

What Henrietta Lacks's story taught me about my role as a doctor

How a key Senate committee is planning to regulate PBMs

knowledge

focus

explore

Drug repurposing or repositioning? The language matters

Novartis develops a rapidly manufactured CAR

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

AstraZeneca bets AAV gene therapy will still deliver the goods

In age of alternative facts, a scholarly course on calling out crap

Doctors have an ethical obligation to be advocates

DIEP, the 'gold standard' of breast reconstruction, is under threat

Apellis safety probe of eye disease drug centers on injection needle

Hepatitis C has a cure — but many Americans still lack access to it

What AAP's gender

explore

Statins reduce cardiovascular risk in people living with HIV

掩盖权钱交易新手段的开创者　　对于上述检方指控，曾志权当庭表示认罪悔罪，这意味着虽然还未最终审判，但其受贿1.4亿元这个数字已经坐实。

Men with early prostate cancer can safely opt out of treatment

Diversity in medical illustrations gets boost from Chidiebere Ibe

Doctors have an ethical obligation to be advocates

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

knowledge

focus

knowledge

entertainment

knowledge

focus

explore

explore

Statins reduce cardiovascular risk in people living with HIV

掩盖权钱交易新手段的开创者 对于上述检方指控，曾志权当庭表示认罪悔罪，这意味着虽然还未最终审判，但其受贿1.4亿元这个数字已经坐实。

Men with early prostate cancer can safely opt out of treatment

Diversity in medical illustrations gets boost from Chidiebere Ibe

Doctors have an ethical obligation to be advocates

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

knowledge

focus

knowledge

entertainment

　　掩盖权钱交易新手段的开创者　　对于上述检方指控，曾志权当庭表示认罪悔罪，这意味着虽然还未最终审判，但其受贿1.4亿元这个数字已经坐实。